IBB vs XLK
iShares Biotechnology ETF vs Technology Select Sector SPDR Fund
IBB—
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: —Yield: —
XLK—
Technology Select Sector SPDR Fund
S&P 500 tech sector pure-play.
Expense: —Yield: —
Side-by-side metrics
| Metric | IBB | XLK |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | iShares | State Street |
IBB top holdings
Holdings data unavailable for IBB.
XLK top holdings
Holdings data unavailable for XLK.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies.
About XLK
XLK (Technology Select Sector SPDR Fund) is S&P 500 tech sector pure-play.